India Ratings revises Wockhardt’s bank facilities ratings

29 Aug 2019 Evaluate

Credit rating agency, India Ratings and Research Private has revised Wockhardt’s ratings for short-term Bank facilities / Commercial Paper to ‘A4+’ from ‘A3’; and for long-term loan facilities rating to ‘BB+ / Negative’ from ‘BBB-/Negative’. The agency has revised the rating of the company owing to refinancing risks, R&D expenses, regulatory overhang etc.

Wockhardt is one of the few companies with end to end integrated capabilities for its products, starting with the manufacture of the oral and sterile API’s, the dose forms and marketing through wholly owned subsidiary in the US, enabling the company to capture maximum value.

Wockhardt Share Price

1445.75 -12.80 (-0.88%)
02-Jan-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1878.00
Dr. Reddys Lab 1373.70
Cipla 1537.55
Lupin 2396.30
Zydus Lifesciences 990.55
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.